Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 9, 2012, Pages 1029-1033

  Prakash, Bhaskaran David ^a   Sitoh, Yih Yian ^a   Tan, Louis C S ^a   Au, Wing Lok ^a  

^a National Neuroscience Institute   (Singapore)

Author keywords

Diffusion tensor imaging; Left right asymmetry; Parkinson's disease

Indexed keywords

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BRAIN ASYMMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANISOTROPY; DIFFUSION TENSOR IMAGING; DISABILITY EVALUATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; SUBSTANTIA NIGRA;

EID: 84869105724     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.05.021     Document Type: Article

References (32)

1. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114(Pt 5):2283-2301.
2. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
3. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992, 32(Suppl):S125-S127.
4. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
5. Sawle G.V., Playford E.D., Brooks D.J., Quinn N., Frackowiak R.S. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naive parkinsonism. Diagnostic implications of the D2 receptor status. Brain 1993, 116(Pt 4):853-867.
6. Lewis M.M., Smith A.B., Styner M., Gu H., Poole R., Zhu H., et al. Asymmetrical lateral ventricular enlargement in Parkinson's disease. Eur J Neurol 2009, 16:475-481.
7. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003, 4:469-480.
8. Hagmann P., Jonasson L., Maeder P., Thiran J.-P., Wedeen V.J., Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and Beyond1. Radiographics 2006, 26:S205-S223.
9. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994, 66:259-267.
10. Pierpaoli C., Jezzard P., Basser P.J., Barnett A., Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201:637-648.
11. Chan L.L., Rumpel H., Yap K., Lee E., Loo H.V., Ho G.L., et al. Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007, 78:1383-1386.
12. Gattellaro G., Minati L., Grisoli M., Mariani C., Carella F., Osio M., et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009, 30:1222-1226.
13. Vaillancourt D.E., Spraker M.B., Prodoehl J., Abraham I., Corcos D.M., Zhou X.J., et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009, 72:1378-1384.
14. Modrego P.J., Fayed N., Artal J., Olmos S. Correlation of findings in advanced MRI techniques with global severity scales in patients with Parkinson disease. Acad Radiol 2011, 18:235-241.
15. Jiang H., van Zijl P.C., Kim J., Pearlson G.D., Mori S. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006, 81:106-116.
16. Oikawa H., Sasaki M., Tamakawa Y., Ehara S., Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002, 23:1747-1756.
17. R Development Core Team R: a language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/R.
18. Harper L., Newman E., Hadley D., Grosset D. Validation of reduced fractional anisotropy measures in the substantia nigra of Parkinson's patients using DAT imaging. Proc Intl Soc Mag Reson Med 2011, 19:2349.
19. Spehlmann R., Stahl S.M. Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals. Lancet 1976, 1:724-726.
20. Clarke P.B., Hommer D.W., Pert A., Skirboll L.R. Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence. Neuroscience 1987, 23:1011-1019.
21. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123:1767-1783.
22. Ferraye M.U., Debu B., Fraix V., Goetz L., Ardouin C., Yelnik J., et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010, 133:205-214.
23. Swaab D.F., Chung W.C., Kruijver F.P., Hofman M.A., Ishunina T.A. Structural and functional sex differences in the human hypothalamus. Horm Behav 2001, 40:93-98.
24. Zhan W., Kang G.A., Glass G.A., Zhang Y., Shirley C., Millin R., et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Move Disord 2012, 27:90-97.
25. van Dyck C.H., Seibyl J.P., Malison R.T., Laruelle M., Zoghbi S.S., Baldwin R.M., et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 2002, 10:36-43.
26. Haaxma C.A., Helmich R.C., Borm G.F., Kappelle A.C., Horstink M.W., Bloem B.R. Side of symptom onset affects motor dysfunction in Parkinson's disease. Neuroscience 2010, 170:1282-1285.
27. Neveu P.J., Betancur C., Barne¥oud P., Vitiello S., Le Moal M. Functional brain asymmetry and lymphocyte proliferation in female mice: effects of right and left cortical ablation. Brain Res 1991, 550:125-128.
28. Pott Godoy Ma.C., Tarelli R., Ferrari C.C., Sarchi MIs, Pitossi F.J. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008, 131:1880-1894.
29. Gerfen C.R., Staines W.A., Fibiger H.C., Arbuthnott G.W. Crossed connections of the substantia nigra in the rat. J Comp Neurol 1982, 207:283-303.
30. Du G., Lewis M.M., Styner M., Shaffer M.L., Sen S., Yang Q.X., et al. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord 2011, 26:1627-1632.
31. Peran P., Cherubini A., Assogna F., Piras F., Quattrocchi C., Peppe A., et al. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain 2010, 133:3423-3433.
32. Yoshikawa K., Nakata Y., Yamada K., Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004, 75:481-484.